Literature DB >> 5921475

Rubella virus infections during pregnancy, Toronto, 1963-66.

D M McLean, G A McNaughton, K F Givan, J M Best, P A Smith, M A Coleman.   

Abstract

Among 670 pregnant women who attended the antenatal clinics of two Toronto city hospitals and one suburban hospital between May 1963 and January 1966, 29 of 550 patients apparently acquired rubella neutralizing antibodies, including 12 whose initial sera were collected during the first trimester. None developed overt rubella. Although rubella antibodies were detected in 61 to 79% of mothers aged 20 years or more, and antibody conversions were detected in 4 to 10% of mothers in each five-year age group between 16 and 39 years, tho rubella syndrome did not appear among any of their offspring. Five of seven other infants, aged 4 to 22 weeks, with the rubella syndrome excreted rubella virus. Rubella neutralizing antibodies were detected in all seven of these infants; these persisted at least 56 weeks in one subject. One mother who received gamma globulin during the first trimester was delivered of an infant who showed signs of the rubella syndrome.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5921475      PMCID: PMC1935836     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  16 in total

1.  VIROLOGIC AND SEROLOGIC STUDIES ON HUMAN PRODUCTS OF CONCEPTION AFTER MATERNAL RUBELLA.

Authors:  C A ALFORD; F A NEVA; T H WELLER
Journal:  N Engl J Med       Date:  1964-12-17       Impact factor: 91.245

2.  Virologic and clinical observations on cytomegalic inclusion disease.

Authors:  T H WELLER; J B HANSHAW
Journal:  N Engl J Med       Date:  1962-06-14       Impact factor: 91.245

3.  THE TERATOGENICITY OF MATERNAL RUBELLA.

Authors:  I J TARTAKOW
Journal:  J Pediatr       Date:  1965-02       Impact factor: 4.406

4.  Rubella virus.

Authors:  J L SEVER; G M SCHIFF; R G TRAUB
Journal:  JAMA       Date:  1962-11-10       Impact factor: 56.272

5.  Prenatal infection with vaccinia virus.

Authors:  G WIELENGA; H van TONGEREN; A H FERGUSON; T van RIJSSEL
Journal:  Lancet       Date:  1961-02-04       Impact factor: 79.321

6.  Rubella Virus Excretion in the "Rubella Syndrome".

Authors:  D M McLean; K F Givan; J M Best; R B Disenhouse
Journal:  Can Med Assoc J       Date:  1965-07-10       Impact factor: 8.262

Review 7.  Coxsackieviruses and echoviruses.

Authors:  D M McLean
Journal:  Am J Med Sci       Date:  1966-03       Impact factor: 2.378

8.  The mumps antigen skin test in endocardial fibroelastosis.

Authors:  J D Shone; S Muñoz Armas; J A Manning; J D Keith
Journal:  Pediatrics       Date:  1966-03       Impact factor: 7.124

9.  INCIDENCE OF RUBELLA ANTIBODIES IN FEMALE SUBJECTS.

Authors:  K F GIVAN; K R ROZEE; A J RHODES
Journal:  Can Med Assoc J       Date:  1965-01-16       Impact factor: 8.262

10.  Viral infections of Toronto children during 1965: II. Measles encephalitis and other complications.

Authors:  D M McLean; J M Best; P A Smith; R P Larke; G A McNaughton
Journal:  Can Med Assoc J       Date:  1966-04-23       Impact factor: 8.262

View more
  2 in total

1.  A survey of rubella antibodies in health personnel and a report of vaccine trial.

Authors:  E Snell; W Stackiw; J C Wilt
Journal:  Can Med Assoc J       Date:  1971-02-06       Impact factor: 8.262

2.  Epidemiological studies on rubella.

Authors:  A Chagnon; V Pavilanis
Journal:  Can Med Assoc J       Date:  1970-05-09       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.